Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs ...
Welcome to Gavi’s 2025 Annual Progress Report, the fifth and final report of Gavi’s 2021–2025 strategic period (Gavi 5.0/5.1). After a year of challenges, Gavi can look forward with optimism; when the ...
If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...
If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...
If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...
If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...
Next-generation TB vaccines, expected to become available from 2029, could deliver major health and economic gains, helping to save an estimated 7.3 million lives, generate up to US$ 135 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results